| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/28/2004 | CN1491664A Composite medicinal preparation containing inosine matters |
| 04/28/2004 | CN1491660A Use of 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-one-4H-1 benzopyranyl-7-hydroxy-beta-D-glucuronic acid in producing medicine |
| 04/28/2004 | CN1491655A Composition for preventing and treating pig Eperythrozoa disease |
| 04/28/2004 | CN1491652A Chemical mixture and its use |
| 04/28/2004 | CN1491651A Use of 23-hydroxy betutic acid in preparing medicine for treating and preventing tumour and AIDS |
| 04/28/2004 | CN1491649A Compound external preparation containing capsicine and nucleoside analogue |
| 04/28/2004 | CN1491644A Fibrauretine slow releasing prepn |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147500C Novel derivatives from class of oleandomycin |
| 04/28/2004 | CN1147493C Oxazolo, thiazole and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof and pharmaceutical composition containing them |
| 04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 04/28/2004 | CN1147316C Process for preparing influenza virus vaccine by static hydraulic inactivation |
| 04/28/2004 | CN1147315C Medicine for treating respiratory tract system disease caused by cold |
| 04/28/2004 | CN1147308C Plaster for treating bone diseases |
| 04/28/2004 | CN1147302C Medicinal bai of bolbstemmatoside B for preventing and controlling human and animal virus disease |
| 04/28/2004 | CN1147298C Prevention and curing agent for hepatitis C |
| 04/28/2004 | CN1147292C Double capsule for the administration of active principles in multiple therepies |
| 04/27/2004 | US6727352 Methods of making macrolides |
| 04/27/2004 | US6727347 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 04/27/2004 | US6727279 Central nervous system disorders |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727269 Acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding |
| 04/27/2004 | US6727267 NS5B HVC polymerase inhibitors |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727248 Substituted quinolinecarboxamides as antiviral agents |
| 04/27/2004 | US6727245 Heterobicyclic derivatives |
| 04/27/2004 | US6727243 Solid solution dissolved in a polymer |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727223 Biosurfactants for blocking the interaction of a pathogen with a collagen receptor |
| 04/27/2004 | US6727093 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by cd8+ class i major histocompatibility complex restricted cytotoxic t-lymphocytes of patients harboring latent human cytomegalovirus infection |
| 04/27/2004 | US6727078 Genetic engineering; removal, insertion gene; lentivirus |
| 04/27/2004 | US6727059 Method for controlling the fidelity and processivity of reverse transcriptase by incorporation and polymerization of nucleotide analogs accepted as substrates for the reverse transcription reaction without blocking its elongation |
| 04/27/2004 | US6726925 Bi-layer membrane comprising phospholipid and lysolipid; drug delivery, medical diagnosis |
| 04/27/2004 | US6726923 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix |
| 04/27/2004 | US6726919 For inducing or maintaining anesthesia or sedation in a patient |
| 04/27/2004 | US6726912 Papillomavirus polyprotein constructs |
| 04/27/2004 | US6726910 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/27/2004 | US6726908 Comprising amoxycillin and potassium clavulanate in a ratio of 10:1 to 20:1 and used in the emperic treatment of infections potentially caused by drug-resistant streptoccocus pneumoniae; respiratory system disorders |
| 04/27/2004 | CA2296244C Adjuvants for use in vaccines |
| 04/27/2004 | CA2256017C .beta.,.beta.-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a |
| 04/27/2004 | CA2104214C Cytokine inhibitors |
| 04/22/2004 | WO2004033702A1 Novel k99-5278 substances and process for producing the same |
| 04/22/2004 | WO2004033463A1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES |
| 04/22/2004 | WO2004033454A1 Therapeutic compounds based on pyrazolopyridine derivatives |
| 04/22/2004 | WO2004033451A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives |
| 04/22/2004 | WO2004033449A1 Antimicrobial 1-aryl dihydropyridone compounds |
| 04/22/2004 | WO2004033441A1 Antibacterial agents |
| 04/22/2004 | WO2004033432A1 Novel pyrazole compounds having antifungal activity |
| 04/22/2004 | WO2004033425A1 Pyrrolidine derivatives for use in treating heaptitis c virus infection |
| 04/22/2004 | WO2004033417A2 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 04/22/2004 | WO2004032959A2 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
| 04/22/2004 | WO2004032958A1 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| 04/22/2004 | WO2004032945A1 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations |
| 04/22/2004 | WO2004032915A1 Anti-influenza virus agent |
| 04/22/2004 | WO2004032911A2 Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor |
| 04/22/2004 | WO2004032899A1 Antibiotic formulation for intramammary administration in milking animals |
| 04/22/2004 | WO2004032832A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 04/22/2004 | WO2004032830A2 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| 04/22/2004 | WO2004032630A1 Agent for controlling protist and/or harmful substance comprising fired product of shell powder |
| 04/22/2004 | WO2004032622A2 Production of peptides in plants as viral coat protein fusions |
| 04/22/2004 | WO2004032599A2 Novel immunogenic proteins of leptospira |
| 04/22/2004 | WO2004022657A8 Increasing of the resorption of substances via skin and mucous membranes |
| 04/22/2004 | WO2004020430A3 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/22/2004 | WO2004018431A3 Novel phenanthridines |
| 04/22/2004 | WO2004013077A3 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 04/22/2004 | WO2004009784A3 Novel inhibitors of kinases |
| 04/22/2004 | WO2004003201A3 Antisense modulation of lrh1 expression |
| 04/22/2004 | WO2004000372A3 Disinfecting composition, cleaning tablet produced therefrom, and use thereof |
| 04/22/2004 | WO2003103571A3 Flavivirus vaccines |
| 04/22/2004 | WO2003097680A3 Anti-bacterial peptides, genes coding for peptides, transformed organisms, vectors, preparation thereof and compositions containing same |
| 04/22/2004 | WO2003096965A3 Use of quinoline derivatives with anti-integrase effect and applications thereof |
| 04/22/2004 | WO2003064625A3 Oligonucleotide compositions with enhanced efficiency |
| 04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |
| 04/22/2004 | WO2003051300A8 Metal complexes and formulations of rifamycin analogues and uses therof |
| 04/22/2004 | WO2003051299A8 Sulfhydryl rifamycins and uses thereof |
| 04/22/2004 | WO2003046506A3 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies |
| 04/22/2004 | WO2003043587A3 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 04/22/2004 | WO2003041686A3 Improved therapy for topical diseases |
| 04/22/2004 | WO2003020763A9 Soluble t cell receptor |
| 04/22/2004 | WO2003015809A9 Antimicrobial cationic peptides and formulations thereof |
| 04/22/2004 | WO2003007878A3 Antifungal agents of sordarin derivatives |
| 04/22/2004 | WO2002092017A8 Human antipneumococcal antibodies from non-human animals |
| 04/22/2004 | WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/22/2004 | WO2002058624A9 In situ generation allicin for the treatment of cancer and infectious diseases |
| 04/22/2004 | WO2000061134A9 Antimicrobial agents |
| 04/22/2004 | WO1991007986A8 Method of treating septic shock |
| 04/22/2004 | US20040078842 Protein with endo-chitinase activity |
| 04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
| 04/22/2004 | US20040077856 Peptide deformylase inhibitors |
| 04/22/2004 | US20040077851 Receptor selective cannabimimetic aminoalkylindoles |
| 04/22/2004 | US20040077850 For treating human/animal gram-positive/negative bacteria infections |
| 04/22/2004 | US20040077847 Nucleic acid encoding a pneumoccocal surface protein c gene or epitope |
| 04/22/2004 | US20040077842 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 04/22/2004 | US20040077840 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroups B epitopes |
| 04/22/2004 | US20040077704 Fused cyclopenta-, cyclohexa-, or cyclohepta(g)indole derivatives as human non-pancreatic secretory phospholipase inhibitors; antiinflammatory agents |
| 04/22/2004 | US20040077702 Administering indazole derivative; or thienyl-, furyl-, or pyrrolyl- fused pyrazole derivative to treat Alzheimer*s, Parkinson*s, or Huntington*s disease |
| 04/22/2004 | US20040077681 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 04/22/2004 | US20040077678 Urea substituted imidazoquinoline ethers |
| 04/22/2004 | US20040077674 Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs |